SEC Form 4 · accession 0001209191-16-095566
GigPeak, Inc. · GIG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avi S Katz
Officer — President and CEO · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 9:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001432150
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2016 | M | 8,050 | $0.00 | A | 310,719 | D | |
| Common StockF2,F3 | Feb 1, 2016 | F | 4,722 | $3.33 | D | 305,997 | D | |
| Common StockF4 | Feb 1, 2016 | M | 19,625 | $0.00 | A | 325,622 | D | |
| Common StockF5,F3 | Feb 1, 2016 | F | 11,511 | $3.33 | D | 314,111 | D | |
| Common StockF6 | Feb 1, 2016 | M | 66,875 | $0.00 | A | 380,986 | D | |
| Common StockF7,F3 | Feb 1, 2016 | F | 35,877 | $3.33 | D | 345,109 | D | |
| Common StockF8 | Feb 1, 2016 | M | 14,908 | $0.00 | A | 360,017 | D | |
| Common StockF9,F3 | Feb 1, 2016 | F | 7,954 | $3.33 | D | 352,063 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs)F1,F10 | $0.00 | Feb 1, 2016 | M | 8,050 | D | — | — | Common Stock | 8,050 | 48,300 | D |
| Restricted Stock Units (RSUs)F4,F11 | $0.00 | Feb 1, 2016 | M | 19,625 | D | — | — | Common Stock | 19,625 | 196,250 | D |
| Restricted Stock Units (RSUs)F6,F12 | $0.00 | Feb 1, 2016 | M | 66,875 | D | — | — | Common Stock | 66,875 | 468,125 | D |
| Restricted Stock Units (RSUs)F8,F13 | $0.00 | Feb 1, 2016 | M | 14,908 | D | — | — | Common Stock | 14,908 | 44,721 | D |
Explanation of responses
- F18,050 Restricted Stock Units ("RSUs") issued in the grant to Dr. Katz on 8/1/2013 vested on 2/1/2016 according to the vesting schedule previously reported.
- F10The RSUs vest as follows: 25% vested on May 1, 2014. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2014 and ending on May 1, 2017, as previously reported.
- F11The RSUs vest as follows: 25% vested on May 1, 2015. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2015 and ending on May 1, 2018, as previously reported.
- F12The RSUs vest in three quarterly installments beginning on May 1, 2015 and ending on November 1, 2015, as previously reported.
- F13The RSUs vest in eight quarterly installments beginning on February 1, 2016 and ending on November 1, 2017, as previously reported.
- F24,722 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F3The closing price of the Company's common stock on 2/1/2016.
- F419,625 RSUs issued in the grant to Dr. Katz on 2/10/2014 vested on 2/1/2016 according to the vesting schedule previously reported.
- F511,511 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F666,875 RSUs issued in the grant to Dr. Katz on 11/19/2015 vested on 2/1/2016 according to the vesting schedule previously reported.
- F735,877 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
- F814,908 RSUs issued in the grant to Dr. Katz on 1/5/2016 vested on 2/1/2016 according to the vesting schedule previously reported.
- F97,954 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.